Summary
Overview
Work History
Education
Skills
Accomplishments
Conferences/Workshops
Projects Dissertation
Publications Posters
Timeline
Generic

Paras Kumar Jha

Principal Scientist
Hyderabad

Summary

Experienced scientist with a proven track record in leading scientific research and driving innovation. Proficient in experimental design, data analysis, and effectively communicating scientific findings. Dedicated to fostering team collaboration and delivering impactful results. Recognized for adaptability and reliability in fast-paced and dynamic work settings.

Overview

12
12
years of professional experience
6
6
years of post-secondary education

Work History

Principal Scientist

Enveda Biosciences
05.2024 - Current
  • Lead team of 4 scientists across multiple small-molecule drug discovery programs, driving different inflammatory projects from early screening to mechanistic validation.
  • Integrated generative AI tools (e.g., ChatGPT, Perplexity) to streamline experimental planning and optimize protocol development, improving efficiency and scientific rigor.
  • Designed, validated, and executed a broad spectrum of in vitro assays targeting diverse signal transduction pathways to support candidate selection and MoA (Mechanism of Action) elucidation.
  • Spearheaded Mode of Action studies for novel chemical entities to guide downstream development decisions.
  • Collaborated on target identification and validation initiatives, contributing to early-stage pipeline expansion.
  • Standardized and validated cell-based assays tailored to in-house discovery programs, ensuring reproducibility and assay robustness.
  • Authored and delivered high-impact scientific presentations for both internal strategy meetings and external stakeholders.

Sr. Associate Scientist

Syngene International Limited
09.2021 - 05.2024
  • Led a team of 3 senior research associates, driving experimental execution, protocol optimization, and adherence to project timelines.
  • Designed and executed cell-based assays (Flow Cytometry, IncuCyte imaging, ELISA, Multiplex) to evaluate bispecific/trispecific antibodies for oncology and autoimmune programs.
  • Analyzed and interpreted data using NovoExpress, IncuCyte, and GraphPad Prism, maintaining ALCOA++ compliance.
  • Managed cell banking operations (including PBMCs) and oversaw reagent/inventory logistics for client-sponsored studies.
  • Developed and standardized in vitro protocols aligned with client goals to support assay development and validation.
  • Created data visualizations and scientific reports for internal teams and external stakeholders using Prism, Excel, and PowerPoint.

Sr. Research Associate

Nektar Therapeutics
02.2017 - 08.2021

· Conducted advanced research on T cell, B cell, and NK cell biology, with a focus on immune modulation and therapeutic efficacy.

· · Acted as the in vivo lead for preclinical biologics programs, supporting study design, execution, and translational data analysis.

· · Designed and implemented both ex vivo and in vivo experiments to evaluate cell-mediated immune responses and immunological endpoints.

· · Developed and refined assays/models for efficacy testing, MoA studies, and candidate selection.

· · Collaborated with in vitro experts to analyze flow cytometry data and recommend data-driven next steps.

· · Delivered scientific insights to align project execution with strategic goals.

· · Managed scientific workflows, including coordination of technical teams and study logistics.

· · Performed data analysis and visualization using GraphPad Prism; prepared reports and presentations for cross-functional and external stakeholders.

· Maintained rigorous experimental documentation in line with data integrity and regulatory compliance standards

Senior Research Biologist

Daiichi Sankyo India Pharma Pvt. Ltd. (DSIN)
12.2014 - 01.2017
  • Acted as the in vivo representative for preclinical studies in the anti-infective therapeutic area focused on small molecules.
  • Developed and optimized in vitro and in vivo models for screening new chemical entities (NCEs), under the mentorship of senior scientists.
  • Collaborated cross-functionally with DMPK, medicinal chemistry, and toxicology teams to ensure seamless project execution.
  • Authored SOPs and study guidelines, ensuring adherence to institutional and regulatory standards.
  • Prepared and defended IAEC (Institutional Animal Ethics Committee) proposals, supporting ethical compliance in animal studies.
  • Maintained study documentation in accordance with quality control (QC) and data integrity guidelines.
  • Performed pharmacokinetic-pharmacodynamic (PK/PD) studies to assess exposure-response relationships of small molecule candidates under the mentorship of senior scientists.

Junior Research Associate Cum Trainer

Singh Biotech LLP
07.2013 - 07.2014
  • Coordinated experimental activities with Senior Research Associates and Research Scientists to ensure smooth project execution.
  • Assisted in project design and protocol standardization, contributing to experimental planning and optimization.
  • Trained new team members and trainees in laboratory techniques and standard operating procedures.
  • Performed routine microbial culture maintenance and ensured the availability and inventory of reagents and consumables.

Education

M. Tech - Biotech

Lovely Professional University
Punjab
07.2011 - 06.2013

B. Tech - Biotech

Lovely Professional University
Punjab
07.2007 - 06.2011

Skills

    Handled multiple inflammatory, infectious, and oncology programs

undefined

Accomplishments

  • Spotlight award for establishment of enzyme assay, 06/02/23
  • Winner of innovation award for creating an in-house chronic UTI mice model, 08/05/16
  • 2nd runner up for team of the year award in annual reward and recognition ceremony organized in a company, 08/05/16
  • Spotlight award for establishment of gut flora mice model which helped the program in a progressive way., 08/28/15

Conferences/Workshops

  • World congress of infectious diseases and antibiotics, IISc Bangalore, 11/28/18 - 11/29/18
  • In vivo preclinical imaging and drug discovery, ACTREC, Navi Mumbai, 09/07/16 - 09/09/16
  • International certificate course on pharmacokinetics /pharmacodynamics, South Asian chapter of American college of clinical pharmacology in collaboration with Bombay college of pharmacy, 04/26/16 - 04/27/16
  • Microcon 2015, JIPMER under the auspices of IAMM, 11/25/15 - 11/29/15
  • Biotechnology: The Go Ahead, Lovely Professional University, 05/09/10

Projects Dissertation

Master's dissertation, Enhancement of alcohol production from agriculture waste and wheat straw by co-culture of Bacillus licheniformis and Zymomonas mobilis., 08/2012 - 04/2013

Publications Posters

  • Synthesis and evaluation of thiomannosides, potent and orally active FimH inhibitors., Sattigeri, J. A., Garg, M., Bhateja, P., Soni, A., Rauf, A. R. A., Gupta, M., Deshmukh, M. S., Jain, T., Alekar, N., Barman, T. K., Jha, P, Chaira, T., Bambal, R. B., Upadhyay, D. J., Nishi, T., Bioorganic & Medicinal Chemistry Letters, 28, 17, 2993-2997, 2018
  • In vivo efficacy and pharmacokinetics of biaryl oxazolidinone RBx 11760 loaded polylactic acid-polyethylene glycol nanoparticles in mouse hematogenous bronchopneumonia and rat groin abscess caused by Staphylococcus aureus., Barman, T. K., Kumar, M., Chaira, T., Dalela, M., Gupta, D., Jha, P.K., Yadav, A.S., Upadhyay, D. J., Raj, V. S., Singh, H., Nanomedicine: Nanotechnology, Biology and Medicine, 14, 4, 1213-1225, 2018
  • Production of bioethanol from wheat straw via optimization of co-culture conditions of Bacillus licheniformis and Saccharomyces cerevisiae., Shweta Sharma, Paras Kumar Jha and Amit Panwar., Discovery Energy, 5, 2021
  • Risk of emergence of resistance to RCI-0656, a novel leucyl-tRNA synthetase inhibitor, in murine urinary tract infection models., Rao, E. P. M., Purnapatre. K., Pandya, Agrawal, A., Jha, P. K., et. al., ASM microbe, New Orleans, USA, 2017
  • In vivo efficacy of a novel Leu-t-RNA synthetase inhibitor Compound A against MDR Pseudomonas aeruginosa 1594965 in a foreign body associated urinary tract infection model., Kumar, M., Pandya, M., Rao, M., Barman, T. K., Joshi, V., Sunkara, S. K., Jha, P. K., Purnapatre, K. P., Agarwal, A., Sattigeri, J. A., Masuda, N., Upadhyay, D. J., 17th ICID conference, Hyderabad, India, 2016

Timeline

Principal Scientist

Enveda Biosciences
05.2024 - Current

Sr. Associate Scientist

Syngene International Limited
09.2021 - 05.2024

Sr. Research Associate

Nektar Therapeutics
02.2017 - 08.2021

Senior Research Biologist

Daiichi Sankyo India Pharma Pvt. Ltd. (DSIN)
12.2014 - 01.2017

Junior Research Associate Cum Trainer

Singh Biotech LLP
07.2013 - 07.2014

M. Tech - Biotech

Lovely Professional University
07.2011 - 06.2013

B. Tech - Biotech

Lovely Professional University
07.2007 - 06.2011
Paras Kumar JhaPrincipal Scientist